City

Andover (2)

Clinton (1)

Colorado Springs (1)

Louisville (1)

Memphis (1)

Shelby (1)

Condition

Ocular Redness (2)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Bausch & Lomb Incorporated (1)

Eye Therapies, LLC (1)

Collaborator

Intervention

brimonidine tartrate 0.025% (1)

brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation (1)

lumify® (brimonidine tartrate ophthalmic solution 0.025%) (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

ocular redness

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Ocular Redness Trial in United States (Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation, Lumify®

Recruiting

Ocular Redness

Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation
Lumify® (brimonidine tartrate ophthalmic solution 0.025%)

Colorado Springs, Colorado
+5 more

Oct 3, 2022

Ocular Redness Trial in Andover (Placebo, Brimonidine tartrate 0.025%)

Completed

Ocular Redness

Placebo
Brimonidine tartrate 0.025%

Andover, Massachusetts

Ora, Inc.

Jul 28, 2014